Provided by Tiger Trade Technology Pte. Ltd.

Viking Therapeutics

28.54
+0.16000.56%
Post-market: 28.570.0300+0.11%16:21 EDT
Volume:5.04M
Turnover:144.14M
Market Cap:3.60B
PE:-6.11
High:29.06
Open:28.39
Low:28.12
Close:28.38
52wk High:43.15
52wk Low:25.77
Shares:126.00M
Float Shares:123.00M
Volume Ratio:0.75
T/O Rate:4.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6676
EPS(LYR):-3.1920
ROE:-88.85%
ROA:-51.86%
PB:8.81
PE(LYR):-8.94

Loading ...

Viking Therapeutics $200M Spot Secondary; price range $35.00-$38.00

TIPRANKS
·
Sep 24

Viking Therapeutics Slips on Planned Stock, Convertible Offerings

Reuters
·
Sep 24

Movement Alert|Viking Therapeutics Falls 8.3% in After-Hours Trading, Profit-Taking Emerges After Two-Day Rally on Obesity Drug Data

Market Focus
·
Sep 24

Viking Therapeutics Plans USD 200 Million Convertible Senior Notes Offering Due 2032

Reuters
·
Sep 24

Viking Therapeutics Announces Proposed Offerings of Common Stock and Convertible Senior Notes

THOMSON REUTERS
·
Sep 24

Viking Therapeutics, - to Offer $200 Mln Common Stock and $200 Mln Convertible Notes Due 2032

THOMSON REUTERS
·
Sep 24

Viking Therapeutics, - Proceeds to Fund Vk2735, Vk3019 Clinical Development and General Corporate Purposes

THOMSON REUTERS
·
Sep 24

Movement Alert|Viking Therapeutics Rises 5.31% in Regular Trading, Obesity Drug VK2735 Maintenance Data Continues to Fuel Rally

Market Focus
·
Sep 24

Viking Therapeutics Price Target Raised to $87.00/Share from $83.00 by Truist Securities

Dow Jones
·
Sep 24

Leerink Partners Sticks to Their Buy Rating for Viking Therapeutics (VKTX)

TIPRANKS
·
Sep 23

The Stock Market is Sleeping on the Next Big AI Catalyst

Dow Jones
·
Sep 23

Canaccord Genuity Remains a Buy on Viking Therapeutics (VKTX)

TIPRANKS
·
Sep 23

These 'Moonshot' Biotech Stocks Could Break Out, Morgan Stanley Says. What Must Go Right.

Dow Jones
·
Sep 23

Viking Therapeutics, Inc. : Truist Securities Raises Target Price to $87 from $83

THOMSON REUTERS
·
Sep 23

Small U.S. Stocks Close Up; Viking Therapeutics Leads Increases

Dow Jones
·
Sep 23

Viking Therapeutics price target raised to $120 from $100 at Oppenheimer

TIPRANKS
·
Sep 23

Top Midday Stories: Goldman Reportedly in Talks to Acquire $37 Billion Credit Firm Palmer Square; Viking Obesity Drug Candidate Showed 'Superior' Results in Study

MT Newswires Live
·
Sep 22

This GLP-1 Drug Helped People Maintain Their Weight Loss in a Clinical Trial - Even for Those Taking it Once a Month

Dow Jones
·
Sep 22

U.S. Stocks on the MOVE-Greenland Mines, GameStop, Shopify

Reuters
·
Sep 22

Roche Says Drug Helped Patients Reduce Blood-Sugar Levels, Weight in Trial

Dow Jones
·
Sep 22